Estrogen (E2) and Progesterone (Pg) via their specific receptors, ER and PR respectively, are major determinants in the development and progression of endometrial malignancies. We have studied how E2 and the synthetic progestin R5020 affect genomic function in Ishikawa endometrial cancer cells. Using ChIPseq in cells exposed to the corresponding hormones, we identified cell specific binding sites for ER (ERbs) and PR (PRbs), mostly binding to independent sites and both adjacent to PAXbs. Long-range interactions (HiC) showed enrichment of PRbs and PAXbs, which we call progestin control regions (PgCRs) inside TADs with differentially progestin-regulated genes. Effects of hormone treatments on gene expression were detected by RNAseq. PgCRs correlate with open chromatin independently of hormonal stimuli. In summary, endometrial response to progestins in differentiated endometrial tumor cells results in part from binding of PR to compartmentalized PgCRs in hormone-independent open chromatin, which include binding of partner transcription factors, in particular PAX2. 65 cells (FC 0.77±0.08 v. OH) ( Figure 1A ). E2-induced cell proliferation was also 66 abrogated by pre-incubation with estrogen receptor (ER) antagonist ICI182780 67 1µM (ICI 10-6M) (FC 1.05±0.05 v. OH) ( Supplementary Fig. S1A ), but not 68 pre-incubation with PR antagonist RU486 1µM (RU486 10-6M) (FC 1.42±0.07 v.
Progesterone (Pg) is a key regulator in the female reproductive tract, including 2 uterine and mammary gland development [1] . Endometrial and breast tissues 3 exhibit significantly different responses to hormones, resulting in very distinctive 4 morphologies and functions. During pregnancy, Pg prepares the uterine epithelium teristic palindrome otherwise found in EREs. 156 Estrogenic environment defines the landscape for PR binding in 157 endometrial cancer cells 158 Sequencing experiments performed on T47D cells exposed to 10 nM R5020 159 revealed over 25 000 PRbs [26, 27] , likely reflecting the high content of PR in these 160 cells. However, a large proportion of these PRbs was considered not functionally 161 relevant as indicated by the lack of nucleosome remodelling in response to hor-162 mone exposure [26] . More recent experiments in T47D exposed to subnanomolar 163 R5020 have revealed that around 2,000 PRbs are sufficient to evoke a functional Supplementary Fig. S4A ). These cells, FPR Ishikawa (FPR), expressed 169 levels of PR comparable to T47D cells ( Supplementary Fig. S4B ) and showed no 170 impairment in hallmark phosphorylation of serine 294 in PR ( Supplementary Fig.   171 S4C), indicating that FPR cells were capable of responding to hormone. Upon hor-172 mone exposure FPR cells exhibited rapid binding of PR to the EGFR enhancer 173 sequence ( Supplementary Fig. S4D ). ChIPseq experiments upon R5020 exposure 174 showed twice the number of PRbs in FPR cells compared to the parental Ishikawa 175 cells. The majority of PRbs identified in Ishikawa cells (>90%) were also detected 176 in FPR cells ( Supplementary Fig. S4E ), meaning that PR overexpression reflected 177 mostly on an increase in number of binding sites. 178 Shifts in the synthesis and secretion of the ovarian steroids (estrogen and pro-179 gesterone) during the menstrual cycle serve as the principal hormonal drivers for 180 endometrial changes. Rising circulating estradiol during the mid-to-late follicu-181 lar phase of the cycle promotes the proliferation of the functional endometrium, 182 and higher E2 levels up-regulate PGR gene expression [6, 7] . To explore the 183 effect of E2 on PR behaviour we performed PR ChIPseq analyses in Ishikawa 184 cells exposed for 12h to E2 (10nM) (preE2) before exposure for 30 and 60min to 185 R5020 (10nM). Pretreatment with E2 significantly increased the intracellular lev-186 els of PR (numbers compared to FPR) as well as the number of R5020-dependent 187 PRbs (prePRbs), which include most of PRbs already identified in non-pretreated 188 Ishikawa cells (Figure 2A , Venn Diagram). Quantitative real-time PCR (qPCR) 189 validations performed on 6 binding sites occupied by no-preE2 and preE2 PR con-190 firmed positioning of the receptor in both conditions ( Supplementary Fig. S4F ). 191 It also showed that E2 pretreatment augments both number of PRbs available for 192 binding and occupancy of the receptor. Contrary to non-pretreated cells (both 193 Ishikawa and FPR cells), PR binding continued to increase after 30 min in preE2 194 7 cells and reached 5701 sites after 60 min of R020 exposure (Figure 2A and plementary Fig. S4G, S4H and S4I) . 196 Upon hormone induction, sites engaged by PR in Ishikawa cells were also oc-197 cupied in FPR and pretreated cells, denoting a strong similarity between them 198 ( Figure 2B ). Using similarity between samples (Jaccard Statistic) as plotting dis-199 tance clearly showed that FPR cells resembled parental Ishikawa cells more than 200 they did pretreated cells. Although a small number of binding sites was shared be- RNAseq experiments performed on Ishikawa cells ( Supplementary Fig. S5 ). Taken 213 together, this evidence suggests that, provided there is an estrogenic background, 214 activated PR could regulate estrogen-dependent Ishikawa-specific transcriptome 215 by binding sites already or formerly bound by ERα.
216
The distribution of PRbs and ERbs in non-pretreated Ishikwa cells, in FPR 217 cells and cells pretreated with E2 (prePRbs) relative to TSS of regulated genes 218 was consistent with previous reports in oher cell lines [26, 28] , in that they were 219 enriched in intronic and distal intergenic regions ( Figure 3 ). Nearly 50% of binding 220 sites localized to distal regions (>50Kb) and approximately 30% to introns other 221 than the first intron, indicating that regulation of gene expression by the steroid 222 receptors PR and ERα is not mediated through proximal promoters but by distal 223 enhancer/silencer sequences.
224
As expected, from the sequences contained in 10kb windows centered in peak 225 summits of PRbs, FPRbs and prePRbs the PRE emerged as the most represen- in an unclear combination of PRE and ERE motifs ( Figure 4B , group e-g). Degen-236 erated motif logo in group g showed no association to any known motif, probably 237 due to a corrupt analysis performed on insufficient data, and the partially degen-238 erated motif logo in group e showed limited association to both PRE and ERE 239 (PRE/ERE).
240
PAX2 binds chromatin in close proximity to ERα and PR binding 241 sites in Ishikawa cells 242 Evidence described so far partially explains cell type specific hormone-243 dependent gene regulation, though it is not sufficient to understand the mecha-244 nisms underlying differential binding of hormone receptors to chromatin. Initially, Figure 4D ), comparison between prePRbs and FPRbs showed 266 that increased PR levels alone were not sufficient for a greater association to PAX 267 binding motifs ( Supplementary Fig. S6F ).
268
PAX association to PR and ERα action was also evaluated by immunofluores- treating Ishikawa cells with E2 ( Figure 5B ). The increase in nuclear PAX2 signal 274 is not due to changes in protein levels, which were not affected by treatment with 275 either R5020 or E2 ( Supplementary Fig. S6G ). In accordance to motif analysis 276 results, PAX2 was not detected in nuclei of T47D cells after hormonal treatments 277 ( Supplementary Fig. S6H ).
278
To extend these findings, we performed PAX2 ChIPseq experiments on un-279 treated cells and in cells exposed for 60min to either R5020 or E2. The results datasets of cells untreated (T0) or pretreated with E2 for 12h, and exposed for 60 297 minutes to R5020 or E2. A comparison of contact matrices at 20 kb resolution of 298 untreated Ishikawa cells to T47D cells confirmed the high degree of conservation 299 in topologically associating domains (TADs) borders ( Supplementary Fig. S7A ). open genomic regions in Ishikawa showed preferential binding of the hormone re-320 ceptors ( Supplementary Fig. S7G ). Neither pre-treatment with E2 nor expression 321 of recombinant PR modified the preferential binding of the PR to the A compart-322 ments.
323
As mentioned above PAX2 binding occurs mostly in close proximity to PR and 324 ERα binding sites. In fact, distances between PAXbs and PRbs were remarkably 325 shorter in E2 pretreated cells than in any other condition ( Figure 6A ). This raised 326 the question of whether recruitment of PR together with PAX2 to open chromatin 327 compartments facilitates regulation of gene expression. To study this notion, we 328 defined putative endometrial regulatory domains that we will name "Progestin 329 Control Regions" (PgCR) with the capacity to potentially regulate nearby genes.
330
The restrictions for being a regulatory domain, which consisted in containing at 331 least two PRbs separated by a maximun distance of 25kb and a PAXbs (represented 332 in scheme above Figure 6B ), were met mostly under E2 pretreated conditions 333 ( Figure 6B ). This outcome was due to the strong association between prePRbs 334 and PAXbs, though it may have been aided by the increased PR protein levels. 335 However, the sole increment in PR protein levels was not enough to force an 336 association to PAXbs, given that FPR cells did not show similar results (Figure 337 6B).
338
Considering that TAD borders may act as regulatory barriers, we removed 339 from further analysis any region that satisfied the rules for being a PgCR while 340 being localized across a barrier as well. In agreement with this restriction, the 341 sizes of PgCR -with an average of 25kb-were smaller than TADs -with an average 342 of 1000kb-( Figure 6C ). In addition, the majority of the 171 identified PgCRs 343 were not located near the TAD borders, but in the TAD center ( Figure 6D ), 344 where most non-housekeeping genes are found [29] . Moreover, PgCRs seem to 345 be located in A compartments in the vecinity of hormone-regulated genes like 346 PGR and ALPP ( Figure 6E ). Expression of these genes was analyzed by qPCR 347 of total RNA samples of Ishikawa cells exposed to hormone for 12h-hormone and 348 showed that ALPP is induced by both hormones and PGR is only induced by E2 349 ( Supplementary Fig. S7H ).
350
As was mentioned before, the HiC matrices were used to determine the spatial 6F, bottom panels), implying that treatments were not responsible for opening 359 the chromatin in these regions. In addition, more than half of hormone-regulated 360 genes were concentrated under 10 megabases away from PgCRs (52% in R5020 361 exposed cells and 51% in E2 exposed cells), including the genes with higher fold 362 change values ( Figure 6G ).
363
These results suggest that specific binding of PR and ERα to chromatin oc- Supplementary Fig. S2A ), coherent with PRB 394 dominance in glandular epithelial cells [36] . 395 To explore the mechanism underlying the endometrial specific response to ovar-396 ian steroids hormones, we studied the genomic binding of ER and PR by ChIPseq 397 in hormone untreated Ishikawa cells and in cells exposed to hormone for different 398 time periods. We discovered that the majority (67%) of PRbs after estradiol pre- tions. After 24h of transfection, cells were exposed to 0.6mg/ml G418 for selection.
468
Then on, every two passages, FRP cells were exposed to a reduced concentration 469 of G418 (0.4mg/ml), except during hormonal treatments.
470
Proliferation assay 471 Ishikawa cells were seeded at 5x10 4 cells/plate density in 35mm dish plates.
472
After 48h in 5% DCC-FCS, the medium was replaced for 1% DCC-FCS for 18h.
473
Treatments were performed for 48h and cells were then collected using trypsin 474 (0.25%). Antagonists for ER and PR, ICI182780 and RU486 1µM respectively, 475 were added for 60min and removed before hormonal treatments. The number of La_Greca_Fig4 Figure 4 . A fraction of E2-induced PRbs localize on ERbs and contain half ERE motifs. (A) Peak signals in PRbs, FPRbs and prePRbs from 60min R5020-treated Ishikawa cells were plotted as heatmaps. Regions were defined inside a window of 10kb centered in peak summit (±5kb) and intensity of the signal correspond to number of reads in each region. Heatmap is subdivided into 4 mutually exclusive groups depending on shared/partly shared/non-shared binding sites: a (n= 1342), sites shared by all three conditions of PR binding; b (n=1072), sites uniquely found in FPR and prePR; c (n=633), sites found only in FPR; and d (n=3162), sites found only in prePR. De novo motif discovery (MEME) was performed on all groups and results are indicated as sequence logos to the right of the map, including the name of the most related known motif and 60min R5020-treated (R5020) Ishikawa cells which were pretreated or not with E2 for 12h (non-pretreated, E2-pretreated). Images were merged for co-localization analysis (merge). Scale bar is shown in the panels and is equivalent to 30µm. (B) Representative images of PAX2 signal (red) in cells treated or not with E2 for 60min and dapi staining (blue). Scale bar is shown in the figure and equals to 30µm. Distribution of intensities in nuclear signal for both conditions is shown to the right of the images. (C) Binding profiles of ER (green), PR (red), FPR (black) and prePR (blue) on PAX2 binding sites of 60min R5020-treated Ishikawa cells. PAX2 binding after 60min E2 treatment was included (purple) (D) Binding profiles as in (C) on PAX2 binding sites of 60min E2-treated Ishikawa cells. PAX2 binding after 60min R5020 treatment was included (orange). 
